Maintenance treatment with medroxyprogesterone acetate in patients with advanced breast cancer responding to chemotherapy: results of a randomized trial. Essen Breast Cancer Study Group. (Q53542638)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Maintenance treatment with medroxyprogesterone acetate in patients with advanced breast cancer responding to chemotherapy: results of a randomized trial. Essen Breast Cancer Study Group.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10472779

Maintenance treatment with medroxyprogesterone acetate in patients with advanced breast cancer responding to chemotherapy: results of a randomized trial. Essen Breast Cancer Study Group. (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10472779

1 reference

based on heuristic

inferred from title

medroxyprogesterone acetate

1 reference

based on heuristic

inferred from title

author name string

Kloke O

1

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10472779

Klaassen U

2

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10472779

Oberhoff C

3

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10472779

Hartwich G

4

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10472779

Szanto J

5

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10472779

Wolf E

6

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10472779

Heckmann M

7

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10472779

Huhn R

8

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10472779

Stephan L

9

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10472779

Schnepper U

10

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10472779

Donsbach GM

11

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10472779

Bechtel C

12

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10472779

Rudolph R

13

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10472779

Berke A

14

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10472779

Borquez D

15

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10472779

Hawig I

16

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10472779

Hirche H

17

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10472779

Schindler AE

18

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10472779

Seeber S

19

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10472779

Becher R

20

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10472779

language of work or name

0 references

publication date

1 May 1999

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10472779

Breast Cancer Research and Treatment

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10472779

55

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10472779

1

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10472779

51-59

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10472779

https://scigraph.springernature.com/pub.10.1023/a:1006169012544

0 references

Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006169012544

21 January 2018

Comparison of short-term and continuous chemotherapy (mitozantrone) for advanced breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006169012544

21 January 2018

Interrupted versus continuous chemotherapy in patients with metastatic breast cancer. The Piedmont Oncology Association

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006169012544

21 January 2018

Weekly doxorubicin with or without high-dose medroxyprogesterone acetate in hormone-resistant advanced breast cancer. A randomised study. The Norwegian Breast Cancer Group.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006169012544

21 January 2018

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006169012544

21 January 2018

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006169012544

21 January 2018

Planning the size and duration of a clinical trial studying the time to some critical event

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006169012544

21 January 2018

A Multiple Testing Procedure for Clinical Trials

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006169012544

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006169012544

21 January 2018

Decreased efficacy of cyclophosphamide, epirubicin and 5-fluorouracil in metastatic breast cancer when reducing treatment duration from 18 to 6 months

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006169012544

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomised trial of six versus twelve courses of chemotherapy in metastatic carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006169012544

7 January 2021

based on heuristic

inferred from DOI database lookup

Second and third line hormonotherapy in advanced post-menopausal breast cancer: a multicenter randomized trial comparing medroxyprogesterone acetate with aminoglutethimide in patients who have become resistant to tamoxifen

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006169012544

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006169012544

7 January 2021

based on heuristic

inferred from DOI database lookup

Feasibility of quality of life assessment in a randomized phase III trial of small cell lung cancer--a lesson from the real world--the Swiss Group for Clinical Cancer Research SAKK

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006169012544

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy for metastatic breast cancer--when is enough enough?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006169012544

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1006169012544

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10472779

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 May 2018

http://europepmc.org/abstract/MED/10472779

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53542638&oldid=1562743340"